These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Bahuau M; Vidaud D; Jenkins RB; Bièche I; Kimmel DW; Assouline B; Smith JS; Alderete B; Cayuela JM; Harpey JP; Caille B; Vidaud M Cancer Res; 1998 Jun; 58(11):2298-303. PubMed ID: 9622062 [TBL] [Abstract][Full Text] [Related]
6. A challenge to p16 gene as a major tumor suppressor. Marx J Science; 1994 Jun; 264(5167):1846. PubMed ID: 8009205 [No Abstract] [Full Text] [Related]
7. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. FitzGerald MG; Harkin DP; Silva-Arrieta S; MacDonald DJ; Lucchina LC; Unsal H; O'Neill E; Koh J; Finkelstein DM; Isselbacher KJ; Sober AJ; Haber DA Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8541-5. PubMed ID: 8710906 [TBL] [Abstract][Full Text] [Related]
8. A cell cycle regulator potentially involved in genesis of many tumor types. Kamb A; Gruis NA; Weaver-Feldhaus J; Liu Q; Harshman K; Tavtigian SV; Stockert E; Day RS; Johnson BE; Skolnick MH Science; 1994 Apr; 264(5157):436-40. PubMed ID: 8153634 [TBL] [Abstract][Full Text] [Related]
9. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759 [TBL] [Abstract][Full Text] [Related]
10. p16 gene in uncultured tumours. Spruck CH; Gonzalez-Zulueta M; Shibata A; Simoneau AR; Lin MF; Gonzales F; Tsai YC; Jones PA Nature; 1994 Jul; 370(6486):183-4. PubMed ID: 8028660 [No Abstract] [Full Text] [Related]
11. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Cairns P; Mao L; Merlo A; Lee DJ; Schwab D; Eby Y; Tokino K; van der Riet P; Blaugrund JE; Sidransky D Science; 1994 Jul; 265(5170):415-7. PubMed ID: 8023167 [No Abstract] [Full Text] [Related]
13. Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. Walker GJ; Hussussian CJ; Flores JF; Glendening JM; Haluska FG; Dracopoli NC; Hayward NK; Fountain JW Hum Mol Genet; 1995 Oct; 4(10):1845-52. PubMed ID: 8595405 [TBL] [Abstract][Full Text] [Related]
14. Role of a cell cycle regulator in hereditary and sporadic cancer. Kamb A Cold Spring Harb Symp Quant Biol; 1994; 59():39-47. PubMed ID: 7587092 [No Abstract] [Full Text] [Related]
15. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system. Wang Y; Becker D Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Kamb A; Shattuck-Eidens D; Eeles R; Liu Q; Gruis NA; Ding W; Hussey C; Tran T; Miki Y; Weaver-Feldhaus J Nat Genet; 1994 Sep; 8(1):23-6. PubMed ID: 7987388 [TBL] [Abstract][Full Text] [Related]
18. Sunlight and melanoma: an answer from MTS1 (p16). Maestro R; Boiocchi M Science; 1995 Jan; 267(5194):15-6. PubMed ID: 7809600 [No Abstract] [Full Text] [Related]
19. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Pollock PM; Pearson JV; Hayward NK Genes Chromosomes Cancer; 1996 Feb; 15(2):77-88. PubMed ID: 8834170 [TBL] [Abstract][Full Text] [Related]
20. Involvement of the p16INK4 (CDKN2) gene in familial melanoma. Naylor MF; Everett MA Melanoma Res; 1996 Apr; 6(2):139-45. PubMed ID: 8791272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]